CELLINK Q5 2020 Results and MatTek Acquisition

Customer centric M&A agenda CELLINK invests in entrepreneurs' enthusiasm and passion for what they do. We aim to find and acquire companies that are built on determined people with a strong desire to create the future of medicine. Financial targets • Revenue growth in line with CELLINK'S . financial targets Potential for EBITDA margins above industry average Proven historical track record of products • and customers Strategic targets • Increase share of ownership of the value chain and improved value proposition • Increased market power and know-how • Potential to branch out into new additional verticals or strengthen regions CELLINK LIFE SCIENCES O CELLINK 2021, All rights reserved.

View entire presentation